Paul McCabe
Worcester, MANPI 1013478239
Payments from drug & device makers
$2,374in general payments, 2019–2025
Across 104 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$407
- AstraZeneca$332
- Pfizer$304
- Boehringer Ingelheim$252
- E.r. Squibb & Sons, L.L.C.$221
- Medtronic$145
- plus $712 from 11 others
What the payments were for
- Food & beverage$2,374100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $407 |
| AstraZeneca | 17 | $332 |
| Pfizer | 13 | $304 |
| Boehringer Ingelheim | 11 | $252 |
| E.r. Squibb & Sons, L.L.C. | 9 | $221 |
| Medtronic | 4 | $145 |
| Kiniksa Pharmaceuticals International, PLC | 7 | $128 |
| Abiomed | 3 | $117 |
| Alnylam Pharmaceuticals Inc. | 4 | $103 |
| Esperion Therapeutics, Inc. | 4 | $90 |
| Penumbra, Inc. | 2 | $71 |
| Boston Scientific | 2 | $53 |
| Lexicon Pharmaceuticals, Inc. | 2 | $39 |
| Novartis | 2 | $35 |
| Bridgebio Pharma, Inc. | 2 | $29 |
| Lantheus Medical Imaging, Inc. | 1 | $26 |
| Bayer | 1 | $22 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.